Första patienten transplanterad

Den första njurtransplantationen har nu utförts i en klinisk studie med Hansa Medicals läkemedelskandidat Ides.

Ideon - Sweden's oldest science park

Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.

Scilifelab får ny site-chef

Utser ny ansvarig för forskningscentrets verksamhet i Stockholm.

Rapid and thorough homogenization of samples

MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.

Astrazeneca i unikt samarbete

Astrazeneca, Göteborgs universitet och Chalmers meddelar i dag att man ingått ett nytt unikt samarbete. - Vi har byggt om våra lokaler för att kunna hysa instru...

Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

Sverige populärast på BIO2009

Rekordmånga besökare kom for att höra Jonas Frisén från Karolinska Institutet berätta om svensk stamcellsforskning.

Fewer visitors but satisfied exhibitors

Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

LEO Pharma - International Clinical Trial Manager

Immunicum levererar till USA

Förser amerikansk institution med adenovirusvektor för Crispr/Cas9-tekniken.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

How to be a perfect mingler

Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Clinical trials in large scale to Stockholm

Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

Acadia drug awarded

Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.

Bioreactor features disposable sensors

The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.

New partnering platform

EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

Så ska USA satsa på life science

I president Obamas budgetförslag för år 2016 nämns bland annat en satsning mot spridningen av antibiotikaresistens och ett initiativ för individanpassad medicin.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.